Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

Fleur de Lune Intimate Spray is shown in this photo posted on the Ontario Cannabis Store website.

HO/The Canadian Press

A perusal of the Ontario Cannabis Store’s online portal on the first day of legalization turned up an array of expected products – various strains of dried weed, oils and tinctures, and accessories needed to use them.

But also on offer is a cannabis-infused “intimate” spray, marketed under the enticingly named Fleur de Lune, which contains eight milligrams of the psychoactive ingredient THC, as well as the cannabinoid CBD.

The only problem is that the Ontario Cannabis Store had initially mislabelled how to apply the product, saying it was for “sublingual” use, which means under the tongue – in other words, orally.

Story continues below advertisement

In fact, the spray made by Hexo Corp. is meant to be applied on the genitals, “particularly for women,” to reduce such symptoms as inflammation and pain, said Terry Lake, the Quebec-based company’s vice-president of corporate social responsibility.

“We always knew there was going to be bumps along the road, no country has done this to this extent,” Lake said of Canada’s rollout of legalized pot.

“It’s a product like many that are used today for intimate areas of the body, but it should be labelled as such … obviously there’s a mistake there that needs to be corrected, so we certainly will be following up with them to ensure that the right information is being given to consumers.”

The product description was corrected by the Ontario Cannabis Store after The Canadian Press reached out for comment. But a spokesperson for the store did not respond to questions about how the error happened, or whether the spray is an appropriate product for the province to be selling.

Asked Wednesday by reporters at the Ontario Legislature about the appropriateness of the spray, Finance Minister Vic Fedeli would only say: “We’ll leave it to the Ontario Cannabis Store to continue to put products out there that the people of Ontario are looking forward to purchasing.”

The 30-millilitre bottle of Fleur de Lune Intimate Spray, which has been approved by Health Canada, sells online for $82.95 and yields about 300 shots of mist.

“The thing about cannabis is that one of the largest areas of concentrations of cannabinoid receptors in the body is in fact the skin,” Lake said Wednesday from Gatineau, Que.

Story continues below advertisement

How much of the spray a consumer should use at a given time is an individual decision, he said, “because when it comes to cannabis ”everyone is different.“

“So there is no one dose that’s right for any one particular person … Everybody responds to cannabis in a different way, and it may be because genetically you respond differently. It may be because you haven’t used cannabis before, so you have a different tolerance level.”

That’s why the marijuana industry advises consumers “to start low and go slow,” Lake added. “See how you respond to the low dose and then go up gradually as you understand the effect it’s having on your body.”

However, one critical aspect to note is that the cannabis-based spray is made with MCT (medium chain triglyceride) oil, which reacts chemically with latex – the substance from which most condoms are made.

As condoms are used to prevent pregnancy and sexually transmitted diseases, “you would have to be very careful,” suggested Lake.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies